Fast Antibacterial Susceptibility Testing by Measuring Electron Transfer Metabolism
|
By LabMedica International staff writers Posted on 07 Dec 2020 |

Image: A recently developed device enables faster testing of antibiotic-resistant bacteria (Photo courtesy of Dr. Seokheun `Sean` Choi)
A recently developed device facilitates bacterial antibiotics susceptibility testing by measuring the effect of these drugs on bacterial electron transfer metabolism.
Since some 2.8 million antibiotic-resistant infections occur annually in the United States with more than 35,000 fatalities, fast and simple antimicrobial susceptibility testing (AST) is urgently required to guide effective antibiotic usages and for monitoring of the antimicrobial resistance rate.
Towards this end, investigators at Binghamton University (NY, USA) established a rapid, quantitative, and high-throughput phenotypic AST by measuring electrons transferred from the interiors of microbial cells to external electrodes. Since the transferred electrons are based on microbial metabolic activities and are inversely proportional to the concentration of potential antibiotics, the changes in electrical outputs can be readily used as a signal to efficiently monitor bacterial growth and antibiotic susceptibility.
For this study, the investigators utilized the common Gram-negative pathogenic bacterium Pseudomonas aeruginosa together with the first-line antibiotic gentamicin. The novel detector had eight sensors printed on a paper surface. The minimum inhibitory concentration (MIC) values generated by the new technique were validated by the gold standard broth microdilution (BMD) method.
Results revealed that the new approach provided quantitative, actionable MIC results within just five hours, as it measured electricity produced by bacterial metabolism instead of the days needed for growth-observation methods.
"To effectively treat the infections, we need to select the right antibiotics with the exact dose for the appropriate duration," said senior author Dr. Seokheun Choi, associate professor of electrical and computer engineering at Binghamton University. "There is a need to develop an antibiotic-susceptibility testing method and offer effective guidelines to treat these infections."
"Although many bacteria are energy-producing, some pathogens do not perform extracellular electron transfer and may not be used directly in our platform. However, various chemical compounds can assist the electron transfer from non-electricity-producing bacteria," said Dr. Choi. "For instance, E. coli cannot transfer electrons from the inside of the cell to the outside, but with the addition of some chemical compounds, they can generate electricity. Now we are working on how to make this technique general to all bacteria cells. We leverage this biochemical event for a new technique to assess the antibiotic effectiveness against bacteria without monitoring the whole bacterial growth. As far as I know, we are the first to demonstrate this technique in a rapid and high-throughput manner by using paper as a substrate."
The new method for determining bacterial antibiotic resistance was published in the November 15, 2020 issue of the journal Biosensors and Bioelectronics.
Related Links:
Binghamton University
Since some 2.8 million antibiotic-resistant infections occur annually in the United States with more than 35,000 fatalities, fast and simple antimicrobial susceptibility testing (AST) is urgently required to guide effective antibiotic usages and for monitoring of the antimicrobial resistance rate.
Towards this end, investigators at Binghamton University (NY, USA) established a rapid, quantitative, and high-throughput phenotypic AST by measuring electrons transferred from the interiors of microbial cells to external electrodes. Since the transferred electrons are based on microbial metabolic activities and are inversely proportional to the concentration of potential antibiotics, the changes in electrical outputs can be readily used as a signal to efficiently monitor bacterial growth and antibiotic susceptibility.
For this study, the investigators utilized the common Gram-negative pathogenic bacterium Pseudomonas aeruginosa together with the first-line antibiotic gentamicin. The novel detector had eight sensors printed on a paper surface. The minimum inhibitory concentration (MIC) values generated by the new technique were validated by the gold standard broth microdilution (BMD) method.
Results revealed that the new approach provided quantitative, actionable MIC results within just five hours, as it measured electricity produced by bacterial metabolism instead of the days needed for growth-observation methods.
"To effectively treat the infections, we need to select the right antibiotics with the exact dose for the appropriate duration," said senior author Dr. Seokheun Choi, associate professor of electrical and computer engineering at Binghamton University. "There is a need to develop an antibiotic-susceptibility testing method and offer effective guidelines to treat these infections."
"Although many bacteria are energy-producing, some pathogens do not perform extracellular electron transfer and may not be used directly in our platform. However, various chemical compounds can assist the electron transfer from non-electricity-producing bacteria," said Dr. Choi. "For instance, E. coli cannot transfer electrons from the inside of the cell to the outside, but with the addition of some chemical compounds, they can generate electricity. Now we are working on how to make this technique general to all bacteria cells. We leverage this biochemical event for a new technique to assess the antibiotic effectiveness against bacteria without monitoring the whole bacterial growth. As far as I know, we are the first to demonstrate this technique in a rapid and high-throughput manner by using paper as a substrate."
The new method for determining bacterial antibiotic resistance was published in the November 15, 2020 issue of the journal Biosensors and Bioelectronics.
Related Links:
Binghamton University
Latest Technology News
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








